Guided Therapeutics (GTHP) Interest Coverage Ratio (2016 - 2025)
Guided Therapeutics' Interest Coverage Ratio history spans 16 years, with the latest figure at 3.86 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 3.17% to 3.86 in Q4 2025 year-over-year; TTM through Dec 2025 was 3.84, a 30.55% increase, with the full-year FY2025 number at 3.84, up 30.52% from a year prior.
- Interest Coverage Ratio hit 3.86 in Q4 2025 for Guided Therapeutics, down from 3.76 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for GTHP hit a ceiling of 0.82 in Q3 2021 and a floor of 21.81 in Q2 2023.
- Historically, Interest Coverage Ratio has averaged 6.52 across 5 years, with a median of 5.03 in 2025.
- Biggest five-year swings in Interest Coverage Ratio: crashed 863.18% in 2022 and later skyrocketed 59.96% in 2024.
- Tracing GTHP's Interest Coverage Ratio over 5 years: stood at 4.35 in 2021, then plummeted by 211.33% to 13.54 in 2022, then surged by 50.26% to 6.74 in 2023, then skyrocketed by 40.84% to 3.99 in 2024, then rose by 3.17% to 3.86 in 2025.
- Business Quant data shows Interest Coverage Ratio for GTHP at 3.86 in Q4 2025, 3.76 in Q3 2025, and 4.86 in Q2 2025.